PRECIGEN Investors

Events & Presentations

Events & Presentations

Upcoming Events

More events are coming soon.

Past Events

Jan 24, 2023 at 4:30 PM EST
Precigen's virtual R&D day event showcased complete clinical trial safety and efficacy data from the Phase 1 dose escalation and expansion cohorts for the PRGN-2012 AdenoVerseTM immunotherapy in recurrent respiratory papillomatosis.
Read More
Dec 12, 2022 at 6:00 PM - 8:00 PM CST
An abstract (Abstract# 4633) titled, "Phase 1/1b Safety Study of PRGN-3006 UltraCAR-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes," was presented as a poster presentation.
Read More
Nov 09, 2022 at 4:30 PM EST
Precigen quarterly financial results and general business update. The conference call may be accessed by dialing 1-888-317-6003 (Domestic US), 1-866-284-3684 (Canada) or 1-412-317-6061 (International) and providing the participant access code 3010378. Participants are asked to dial in 10-15 minutes in advance of the scheduled call time to facilitate timely connection to the call.
Read More